Urokinase for Injection 5000IU(3mg)

Urokinase for Injection 5000IU(3mg) Technical Specification:

GENERIC NAME OF MEDICINAL PRODUCT:

• Urokinase for Injection 5000IU(3mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Urokinase for Injection 5000IU(3mg)
  Each vial contains:
  Urokinase IP…………….……………5000IU
  Excipients………………………………………q.s

THERAPEUTIC INDICATION:

UROKINASE breaks up blood clots. It is used to treat large blood clots formed in the lungs. This medicine may be used for other purposes. Urokinase is a physiologic thrombolytic agent that is produced in renal parenchymal cells. Unlike streptokinase, urokinase directly cleaves plasminogen to produce plasmin. When it is purified from human urine.

CAUTION AND SCHEDULE:

CAUTION: Injection should not be used if it contains visible particulate matter after reconstitution.

SCHEDULE: SCHEDULE ‘H’ PRESCRIPTION DRUG; WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store at 25°C. Store in a cool, dry & dark place. Protect from light

FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE

KEEP OUT OF REACH OF CHILDREN

DOSAGE: As directed by the Physician

Urokinase for Injection 5000 IU (3mg) Manufacturer Supplier in India

The global pharmaceutical industry continues to witness increasing demand for high-quality thrombolytic medicines used in emergency and critical care treatments. Among these life-saving medicines, Urokinase for Injection 5000 IU (3mg) has emerged as one of the most effective thrombolytic agents for dissolving dangerous blood clots and restoring normal blood circulation. Hospitals, government healthcare organizations, distributors, and pharmaceutical importers across the globe are actively seeking reliable manufacturers capable of supplying this specialized injectable medicine with international quality standards.

When it comes to choosing a dependable Urokinase for Injection 5000 IU (3mg) Manufacturer in India, Taj Pharma has earned a strong reputation for manufacturing premium-quality injectable pharmaceuticals that comply with stringent international manufacturing standards. With decades of pharmaceutical expertise, advanced manufacturing technology, regulatory compliance, and a robust export network, Taj Pharma serves healthcare providers and pharmaceutical importers across multiple continents.

Introduction to Urokinase for Injection 5000 IU (3mg)

Urokinase for Injection 5000 IU (3mg) is a thrombolytic or clot-dissolving medicine primarily used to break down harmful blood clots that obstruct blood vessels. The medicine activates plasminogen into plasmin, an enzyme responsible for dissolving fibrin clots. This mechanism helps restore blood flow to affected organs and significantly reduces complications associated with vascular blockages.

Medical specialists administer this medicine under strict hospital supervision because accurate dosage and continuous monitoring are essential for patient safety.

The medicine is commonly prescribed for patients suffering from:

• Recent heart attack (Acute Myocardial Infarction)
• Pulmonary Embolism (PE)
• Acute Ischemic Stroke (selected patients)
• Peripheral arterial thrombosis
• Blocked intravenous catheters
• Certain vascular occlusions

Due to the increasing incidence of cardiovascular diseases worldwide, the demand for Urokinase for Injection 5000 IU (3mg) continues to grow rapidly in both developed and developing healthcare markets.

Urokinase for Injection 5000 IU (3mg) Manufacturer in India

Taj Pharma is recognized as a leading Urokinase for Injection 5000 IU (3mg) Manufacturer, Supplier, and Exporter in India, offering pharmaceutical products manufactured under strict quality assurance systems.

The company is committed to delivering medicines that meet international pharmacopeial standards while maintaining affordability and reliability for global healthcare providers.

Manufactured using advanced sterile production technology, every batch undergoes comprehensive quality testing before dispatch to ensure purity, potency, sterility, and safety.

Taj Pharma supplies this product across India and exports to numerous international markets through an efficient global distribution network.

Possible Side Effects

Like all thrombolytic medicines, Urokinase for Injection 5000 IU (3mg) may cause certain side effects.

Common side effects include:

• Nausea
• Vomiting
• Injection site bleeding
• Allergic reactions
• Temporary decrease in blood pressure

Since this medicine promotes clot dissolution, patients may also experience an increased risk of bleeding. Physicians carefully evaluate the benefits and potential risks before initiating treatment.

Patients should never discontinue prescribed cardiovascular medicines without consulting their healthcare provider, as doing so may increase the risk of another heart attack or stroke.

Why Global Buyers Choose Taj Pharma

International pharmaceutical buyers prefer suppliers capable of maintaining consistent quality, timely deliveries, and complete regulatory compliance.

Taj Pharma offers all these advantages through:

• Advanced sterile injectable manufacturing facilities
• Experienced pharmaceutical production teams
• Strict quality control procedures
• International regulatory documentation
• Competitive pricing
• Reliable export logistics
• Dedicated customer support
• Long-term business partnerships

These strengths have made Taj Pharma one of India’s most trusted pharmaceutical exporters.

Product Technical Specification

Regulatory Documentation for International Buyers

One of the most important considerations for pharmaceutical importers is regulatory compliance. Every country has its own registration procedures, technical requirements, and documentation standards before approving the import and sale of pharmaceutical products.

As a globally recognized Urokinase for Injection 5000 IU (3mg) Manufacturer in India, Taj Pharma supports international buyers by providing comprehensive regulatory documentation that simplifies product registration and accelerates market entry.

The company works closely with importers, government procurement agencies, hospitals, institutional buyers, and pharmaceutical distributors to ensure that all required documentation is available according to the destination country’s regulatory authority.

Depending on customer requirements, Taj Pharma can provide documentation such as:

• WHO-GMP Certificate
• Certificate of Pharmaceutical Product (COPP)
• Certificate of Analysis (COA)
• Certificate of Origin (COO)
• Free Sale Certificate (FSC)
• Batch Manufacturing Record (BMR)
• Batch Packing Record (BPR)
• Material Safety Data Sheet (MSDS), where applicable
• Stability Study Reports
• Validation Documents
• Sterility Test Reports
• Product Specifications
• Finished Product Testing Reports
• Common Technical Document (CTD) Dossier
• ACTD Dossier
• Product Master File (PMF), where applicable

This comprehensive documentation package helps pharmaceutical importers complete product registrations efficiently while ensuring compliance with international pharmaceutical regulations.

WHO-GMP Manufacturing Excellence

Quality remains the foundation of every pharmaceutical product manufactured by Taj Pharma.

The manufacturing facilities follow stringent Good Manufacturing Practices (GMP), ensuring that every stage—from raw material procurement to final packaging—is performed under controlled conditions.

Quality assurance includes:

• Raw material qualification
• In-process quality control
• Sterility testing
• Microbiological analysis
• Finished product inspection
• Stability monitoring
• Batch traceability
• Controlled storage conditions

Every production batch undergoes rigorous quality evaluation before release to ensure consistency, safety, purity, and efficacy.

Advanced Manufacturing Infrastructure

Taj Pharma has invested significantly in modern pharmaceutical manufacturing infrastructure designed to meet international standards.

The manufacturing process incorporates:

• Sterile injectable production areas
• Cleanroom environments
• HEPA-filtered air handling systems
• Automated filling and sealing equipment
• Environmental monitoring systems
• Controlled lyophilization technology
• Modern analytical laboratories
• Dedicated quality assurance departments

These advanced facilities enable the production of high-quality injectable medicines with excellent batch-to-batch consistency.

Product Storage and Shelf Life

Maintaining product stability throughout transportation and storage is essential for injectable medicines.

Recommended Storage Conditions

• Store below 25°C
• Protect from direct sunlight
• Keep away from excessive moisture
• Store in original packaging
• Do not freeze unless specified

Shelf Life

Under recommended storage conditions, Urokinase for Injection 5000 IU (3mg) generally has a shelf life of 24 months from the date of manufacture (subject to approved product specifications and stability data).

Each shipment is supplied with adequate remaining shelf life in accordance with importer requirements.

Export Certifications Available

International pharmaceutical buyers often require certification before importing medicines into their respective countries.

Taj Pharma supports exports with internationally recognized certifications, including:

• WHO-GMP Certification
• Certificate of Pharmaceutical Product (COPP)
• Free Sale Certificate
• Certificate of Origin
• Certificate of Analysis
• GMP Compliance Documentation
• Stability Data
• CTD Dossier
• ACTD Dossier
• Validation Reports
• Product Registration Support
• Export Documentation Assistance

This extensive regulatory support helps reduce registration timelines and facilitates smoother import processes.

Global Supply Chain and Logistics Support

Timely delivery is critical for life-saving pharmaceutical products.

Taj Pharma maintains an efficient global supply chain supported by experienced export professionals who coordinate manufacturing, documentation, customs clearance, and international logistics.

The company provides:

• Air freight shipments
• Sea freight exports
• Temperature-conscious handling where required
• Export documentation support
• Customs clearance assistance
• Shipment tracking
• Bulk commercial supply
• Government tender fulfillment

This integrated logistics network enables reliable deliveries to healthcare providers worldwide.

Target Export Markets

Taj Pharma exports pharmaceutical products to numerous regulated and semi-regulated markets around the world.

Major export destinations include:

United Arab Emirates | Saudi Arabia | Oman | Qatar | Kuwait | Bahrain | Iraq | Yemen | Kenya | Nigeria | Ghana | Tanzania | Uganda | Ethiopia | South Africa | Sri Lanka | Nepal | Bangladesh | Philippines | Vietnam

The company continues to expand its international presence by developing long-term partnerships with pharmaceutical importers and distributors across emerging and established healthcare markets.

Why Global Importers Trust Taj Pharma

International buyers choose Taj Pharma because of its commitment to quality, transparency, and customer satisfaction.

Key advantages include:

• WHO-GMP manufacturing standards
• Modern sterile injectable facilities
• Highly qualified technical professionals
• Competitive pricing
• Reliable production capacity
• Complete export documentation
• Customized packaging solutions
• Fast order processing
• Strong global logistics network
• Responsive customer support

By combining pharmaceutical expertise with international business capabilities, Taj Pharma has established itself as a preferred manufacturing partner for buyers seeking dependable pharmaceutical products from India.

Affordable Pricing Without Compromising Quality

For pharmaceutical importers, distributors, hospitals, and government procurement agencies, balancing quality with cost is essential. Taj Pharma understands this need and has developed efficient manufacturing processes that help optimize production costs while maintaining stringent quality standards.

As a leading Urokinase for Injection 5000 IU (3mg) Manufacturer in India, Taj Pharma offers competitive pricing supported by:

• Economies of scale in manufacturing
• Efficient procurement of pharmaceutical-grade raw materials
• Modern automated production systems
• Robust quality assurance processes
• Optimized supply chain management
• Flexible commercial terms for bulk buyers

These advantages enable international buyers to source premium-quality products at competitive prices while ensuring consistent product availability.

Comprehensive Quality Assurance

Quality is integrated into every stage of the manufacturing process. From raw material sourcing to finished product release, each batch undergoes multiple quality checks to ensure compliance with applicable pharmacopeial and regulatory standards.

Quality assurance includes:

• Vendor qualification
• Incoming raw material testing
• In-process quality monitoring
• Sterility testing
• Potency analysis
• Identity and purity testing
• Packaging inspection
• Batch release by qualified quality personnel
• Stability monitoring

This systematic approach helps ensure that every vial of Urokinase for Injection 5000 IU (3mg) meets the required quality specifications before shipment.

Call to Action

General Enquiries: +91 84484 44095

WhatsApp Support:
+91 74 0000 9975
+91 74 0000 9976

Email:
info@tajpharma.com
tajgroup@tajpharma.com

Top 20 FAQs

1. What is Urokinase for Injection 5000 IU (3mg)?

It is a thrombolytic medicine used to dissolve harmful blood clots and restore normal blood flow.

2. What conditions is it used to treat?

It is commonly used for pulmonary embolism, selected cases of acute ischemic stroke, catheter occlusion, and certain thrombotic conditions. Treatment decisions depend on the patient’s clinical status and physician judgment.

3. How is it administered?

It is administered by qualified healthcare professionals under medical supervision.

4. Can patients self-administer this medicine?

No. It should only be administered in a clinical setting under appropriate medical supervision.

5. What are the common side effects?

Common side effects include nausea, vomiting, injection-site bleeding, allergic reactions, and decreased blood pressure.

6. Does it increase bleeding risk?

Yes. Because it dissolves blood clots, it can increase the risk of bleeding.

7. Is a prescription required?

Yes. It is a prescription-only medicine.

8. What dosage strength is available?

This product is available as Urokinase for Injection 5000 IU (3mg).

9. What is the dosage form?

Lyophilized powder for injection.

10. How should it be stored?

Store below 25°C, protected from light and moisture, following the approved product labeling.

11. What is the shelf life?

Typically up to 24 months when stored under recommended conditions and according to approved specifications.

12. Does Taj Pharma export internationally?

Yes. Taj Pharma supplies pharmaceutical products to numerous international markets.

13. Is custom packaging available?

Yes. Private labeling and customized export packaging are available.

14. Can distributors obtain regulatory documentation?

Yes. Documentation is provided based on customer and market requirements.

15. Does Taj Pharma provide CTD dossiers?

Yes, where applicable for product registration requirements.

16. What certifications support exports?

Available documentation may include WHO-GMP, COPP, COA, FSC, Certificate of Origin, and other supporting documents, depending on product and market requirements.

17. Can hospitals purchase directly?

Hospitals, institutional buyers, and authorized procurement organizations may contact Taj Pharma to discuss supply options.

18. Does Taj Pharma support government tenders?

Yes. The company supports institutional and tender-based procurement where applicable.

19. Is contract manufacturing available?

Yes. Taj Pharma offers contract manufacturing and private-label services for eligible partners.

20. How can international buyers request a quotation?

Buyers can contact Taj Pharma through the provided telephone numbers, WhatsApp support, or email to discuss pricing, documentation, and supply requirements.